⌘K
Loading ticker…
TScan Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, TScan Therapeutics, Inc. Common Stock (TCRX) has a 3-month relative strength percentile of 31 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.4%, relative volume 1.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
31 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
TCRX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $583K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TCRX Jan avg: -2.10% median: -5.17% win: 50% σ: 15.07% n: 4 2022-04-12 → 2026-05-29 | TCRX Feb avg: 19.95% median: 18.01% win: 75% σ: 34.84% n: 4 2022-04-12 → 2026-05-29 | TCRX Mar avg: -12.55% median: -16.77% win: 25% σ: 23.87% n: 4 2022-04-12 → 2026-05-29 | TCRX Apr avg: 3.16% median: 8.09% win: 60% σ: 15.30% n: 5 2022-04-12 → 2026-05-29 | TCRX May avg: 8.62% median: 1.32% win: 60% σ: 23.96% n: 5 2022-04-12 → 2026-05-29 | TCRX Jun avg: -5.80% median: -0.16% win: 50% σ: 17.73% n: 4 2022-04-12 → 2026-05-29 (current) | TCRX Jul avg: 17.81% median: 21.03% win: 75% σ: 20.76% n: 4 2022-04-12 → 2026-05-29 | TCRX Aug avg: -12.20% median: -8.85% win: 50% σ: 20.80% n: 4 2022-04-12 → 2026-05-29 | TCRX Sep avg: 2.01% median: 4.34% win: 75% σ: 9.91% n: 4 2022-04-12 → 2026-05-29 | TCRX Oct avg: 9.17% median: -1.12% win: 50% σ: 28.61% n: 4 2022-04-12 → 2026-05-29 | TCRX Nov avg: 2.97% median: -7.47% win: 50% σ: 48.53% n: 4 2022-04-12 → 2026-05-29 | TCRX Dec avg: -21.29% median: -19.48% win: 0% σ: 13.09% n: 4 2022-04-12 → 2026-05-29 |